Condensed cyclic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device

US12297214B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12297214-B2
Application numberUS-202117400727-A
CountryUS
Kind codeB2
Filing dateAug 12, 2021
Priority dateAug 13, 2020
Publication dateMay 13, 2025
Grant dateMay 13, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are a condensed cyclic compound represented by Formula 1-1 or 1-2, an organic light-emitting device including the condensed cyclic compound, and an electronic apparatus including the organic light-emitting device: wherein Formulae 1-1 and 1-2 are the same as described in the present specification.

First claim

Opening claim text (preview).

What is claimed is: 1. A condensed cyclic compound represented by Formula 1-1 or 1-2: wherein, in Formulae 1-1 and 1-2, CY 1 to CY 3 are each independently a C 5 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, at least one of CY 1 and CY 2 is a group represented by Formula 2-1 or 2-2, X 1 is O, S, Se, Te, N(R 1a ), or C(R 1a )(R 1b ), X 2 is O, S, Se, Te, N(R 2a ), or C(R 2a )(R 2b ), Y 1 is O, S, Se, Te, N(R 3a ), or C(R 3a )(R 3b ), Z 1 is B, Al, Si(R 4a ), Ge(R 4a ), P, P(═O), or P(═S), R 1 to R 3 , R 1a to R 4a , and R 1b to R 3b are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkenyl group unsubstituted or substituted with at least one R 10a , a C 2 -C 60 alkynyl group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 alkoxy group unsubstituted or substituted with at least one R 10a , a C 3 -C 60 carbocyclic group unsubstituted or substituted with at least one R 10a , a C 1 -C 60 heterocyclic group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 aryloxy group unsubstituted or substituted with at least one R 10a , a C 6 -C 60 arylthio group unsubstituted or substituted with at least one R 10a , —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —C(═O)(Q 1 ), —S(═O) 2 (Q 1 ), or —P(═O)(Q 1 )(Q 2 ), R 1 to R 3 , R 1a to R 4a , and R 1b to R 3b are optionally linked to each other or via a single bond to form a C 8 -C 60 polycyclic group that is unsubstituted or substituted with at least one R 10a , d1 to d3 are each independently an integer from 0 to 20, in Formulae 2-1 and 2-2, CY 11 and CY 12 are each independently a C 5 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, or a group represented by Formula 3, CY 13 is condensed with CY 1 , CY 2 , or each of CY 1 and CY 2 , wherein one of the bonds marked with a dotted line in CY 13 indicates a binding site to a bond marked with a solid line in CY 1 or CY 2 , in Formula 3, CY 31 to CY 33 are each independently a C 5 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, X 31 is O, S, Se, Te, N(R 5a ), or C(R 5a )(R 5b ), X 32 is O, S, Se, Te, N(R 6a ), or C(R 6a )(R 6b ), Z 31 is B, Al, Si(R 7a ), Ge(R 7a ), P, P(═O), or P(═S), R 5a to R 7a , R 5b , and R 6b are each independently the same as described in connection with R 1a , R 10a is: deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, or a nitro group; a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, or a C 1 -C 60 alkoxy group, each unsubstituted or substituted with deuterium, —F, —C 1 , —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), —P(═O)(Q 11 )(Q 12 ), or any combination thereof; a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, or a C 6 -C 60 arylthio group, each unsubstituted or substituted with deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 60 carbocyclic group, a C 1 -C 60 heterocyclic group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), —P(═O)(Q 21 )(Q 22 ), or any combination thereof: or —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), or —P(═O)(Q 31 )(Q 32 ), and Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 , and Q 31 to Q 33 are each independently: hydrogen; deuterium; —F; —Cl; —Br; —I; a hydroxyl group; a cyano group; a nitro group; a C 1 -C 60 alkyl group: a C 2 -C 60 alkenyl group: a C 2 -C 60 alkynyl group; a C 1 -C 60 alkoxy group; or a C 3 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group, each unsubstituted or substituted with deuterium, —F, a cyano group, a C 1 -C 60 alkyl group, a C 1 -C 60 alkoxy group, a phenyl group, a biphenyl group, or any combination thereof. 2. The condensed cyclic compound of claim 1 , wherein CY 1 to CY 3 are each independently a benzene group, a naphthalene group, an anthracene group, a phenanthrene group, a triphenylene group, a pyrene group, a chrysene group, a cyclopentadiene group, a 1,2,3,4-tetrahydronaphthalene group, a thiophene group, a furan group, an indole group, a benzoborole group, a benzophosphole group, an indene group, a benzosilole group, a benzogermole group, a benzothiophene group, a benzoselenophene group, a benzofuran group, a carbazole group, a dibenzoborole group, a dibenzophosphole group, a fluorene group, a dibenzosilole group, a dibenzogermole group, a dibenzothiophene group, a dibenzoselenophene group, a dibenzofuran group, a dibenzothiophene 5-oxide group, a 9H-fluorene-9-one group, a dibenzothiophene 5,5-dioxide group, an azaindole group, an azabenzoborole group, an azabenzophosphole group, an azaindene group, an azabenzosilole group, an azabenzogermole group, an azabenzothiophene group, an azabenzoselenophene group, an azabenzofuran group, an azacarbazole group, an azadibenzoborole group, an azadibenzophosphole group, an azafluorene group, an azadibenzosilole group, an azadibenzogermole group, an azadibenzothiophene group, an azadibenzoselenophene group, an azadibenzofuran group, an azadibenzothiophene 5-oxide group, an aza-9H-fluorene-9-one group, an azadibenzothiophene 5,5-dioxide group, an indolocarbazole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a phenanthroline group, a pyrrole group, a pyrazole group, an imidazole group, a triazole group, an oxazole group, an isooxazole group, a thiazole group, an isothiazole group, an oxadiazole group, a thiadiazole group, a benzopyrazole group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzoxadiazole group, a benzothiadiazole group, a 5,6,7,8-tetrahydroisoquinoline group, a 5,6,7,8-tetrahydroquinoline group, or a group represented by Formula 2-1 or 2-2. 3. The condensed cyclic compound of claim 1 , wherein CY 3 is a benzene group, a naphthalene group, a dibenzosilole group, a carbazole group, a dibenzothiophene group, or a dibenzofuran group. 4. The condensed cyclic compound of claim 1 , wherein CY 11 and CY 12 are each independently a benzene group or a group represented by Formula 3. 5. The condensed cyclic compound of claim 1 , wherein the condensed cyclic compound represented by Formula 1-1 or 1-2 satisfies at least one of Conditions 1 to 3: Condition 1 CY 1 is a group represented by Formula 2-1 or 2-2; Condition 2 CY 2 is a group represented by Formula 2-1 or 2-2; and Condition 3 CY 1 and CY 2 are each independently a group represented by Formula 2-1 or 2-2. 6. The condensed cyclic compound of claim 1 , wherein in Formula 1-1, a moiety represented by is represented by one of Formulae 3-1 to 3-8, and in Formula 1-1, a moiety represented by

Assignees

Inventors

Classifications

  • containing other heteroatoms · CPC title

  • for assisting energy transfer, e.g. sensitization · CPC title

  • Organoboranes · CPC title

  • comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole · CPC title

  • Highest occupied molecular orbital [HOMO], lowest unoccupied molecular orbital [LUMO] or Fermi energy values · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12297214B2 cover?
Provided are a condensed cyclic compound represented by Formula 1-1 or 1-2, an organic light-emitting device including the condensed cyclic compound, and an electronic apparatus including the organic light-emitting device: wherein Formulae 1-1 and 1-2 are the same as des…
Who is the assignee on this patent?
Samsung Electronics Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07F5/027. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 11 related publications on this page (citations in our corpus or others sharing the same primary CPC).